Latest / Stock Movers / Apple Jumps, Goldman Rises, Pfizer Lower After Abandoning Obesity Pill
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news, The Stock Movers podcast,
- 0:10Speaker 1: your roundup of companies making moves in the stock market,
- 0:14Speaker 1: harnessing the power of Bloomberg Data.
- 0:17Speaker 2: It's a good day in the stock market, Banana, what
- 0:19Speaker 2: are you looking at?
- 0:20Speaker 3: It is a good day, and we already mentioned Apple.
- 0:22Speaker 3: I'm looking at shairs of Apple, which are rallying about
- 0:24Speaker 3: four percent after the Trump administration said it was exempting
- 0:28Speaker 3: things like phones, computers, some popular electronics from its so
- 0:32Speaker 3: called reciprocal tariffs. So we have those exclusions applying to
- 0:37Speaker 3: a number of things, including products from Apple, obviously, although
- 0:42Speaker 3: we did hear from the administration afterwards saying that the
- 0:47Speaker 3: President is pledging that he will still apply tariffs to
- 0:51Speaker 3: some popular consumer electronics. So a lot of analysts and
- 0:54Speaker 3: strategists are looking at this and thinking that maybe the
- 0:57Speaker 3: reprieve is seeming temporary, and looking at shares of Goldman,
- 1:01Speaker 3: which reported earnings on Monday, and we have the stock
- 1:04Speaker 3: traders posting their highest quarterly revenue hall on record. Obviously,
- 1:10Speaker 3: it's thanks to volatile markets, which we have had plenty
- 1:13Speaker 3: of recently. We had Goldman saying equity trading revenues rose
- 1:16Speaker 3: twenty seven percent from a year earlier to four point
- 1:19Speaker 3: one nine billion dollars for the first three months of
- 1:22Speaker 3: the year. And we had JP, Morgan Chase and Morgan
- 1:26Speaker 3: Stanley last week telling us a similar story, notching record
- 1:30Speaker 3: stock trading halls for the period.
- 1:32Speaker 2: But I'd see here that mister Solomon, the CEO of Goldman,
- 1:35Speaker 2: saying no fundamental shift on macro slowing MNA dialogues here.
- 1:41Speaker 2: So the traders are having a good time, but there's
- 1:44Speaker 2: some concern from the advisory side of the business.
- 1:46Speaker 3: Deal Making is remaining challenging, obviously because of all of
- 1:49Speaker 3: the uncertainty coming from the White House in terms of
- 1:53Speaker 3: what can happen with MNA deals, et cetera. And the
- 1:56Speaker 3: third company I'm looking at is Pfizer. It said it's
- 1:59Speaker 3: going to stop developing an obesity pill that investors had
- 2:02Speaker 3: been really closely tracking and watching after the said pill
- 2:08Speaker 3: was potentially linked to a liver injury in one of
- 2:12Speaker 3: the patients, so they had to stop that trial. And
- 2:14Speaker 3: the company said it won't be advancing this once daily
- 2:18Speaker 3: medicine into the final stages of testing and it will
- 2:21Speaker 3: instead be investing in earlier stage treatments for obesity and
- 2:25Speaker 3: we have shares of Pfizer up about half a percentage
- 2:28Speaker 3: point today.
- 2:30Speaker 1: The Stock Movers podcast from Bloomberg Radio. Check back with
- 2:35Speaker 1: us throughout the day for the latest roundup of companies
- 2:37Speaker 1: making news on Wall Street and for the latest market
- 2:40Speaker 1: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 2:45Speaker 1: Bloomberg dot com, and on Applecarplay and Android Auto with
- 2:48Speaker 1: the Bloomberg Business app.